Coronary artery disease trials in Argentina

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Product Surveillance Registry

  Where

  Buenos Aires

  People

  100,000 worldwide

  Run by

  Medtronic

  See details and how to joinNCT01524276
• Phase 2/3Taking people
  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  Where

  Banfield, Buenos Aires, Ciudad Autonoma, Ciudad de Buenos Aires, Ciudad Evita, Córdoba, Formosa, Hurlingham, Mar del Plata, Morón, Rosario, San Fernando, San Miguel de Tucumán, Santa Fe

  Age

  18 years and over

  People

  3,110 worldwide

  Run by

  CSL Behring

  See details and how to joinNCT05485961 · EU 2022-500273-14-00
• Phase 3Taking people
  Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes

  Where

  Capital Federal

  Age

  18 years and over

  People

  300 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07102628
• No phaseTaking people
  Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

  Where

  Buenos Aires, Córdoba

  Age

  18 years and over

  People

  150 worldwide

  Run by

  McMaster University

  See details and how to joinNCT05646394
• No phaseEnrolling by invitation
  Whole Blood Transcriptomic Signal According to Coronary Atherosclerotic Plaque Burden Assessed by CT Angiography

  Where

  Ciudad Autónoma de Buenos Aire

  Age

  18 years to 75 years

  People

  200

  Run by

  MultiplAI Health Limited

  See details and how to joinNCT06194526